
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
05/14/2025 | Q1 | -- | $1.1M | -$0.24 | -- | -- |
12/31/2024 | Q4 | -- | $1.1M | -$0.40 | -- | -- |
11/13/2024 | Q3 | -- | $1.1M | -$0.60 | -- | -- |
08/14/2024 | Q2 | -- | $924.9K | -$0.90 | -- | -- |
05/15/2024 | Q1 | -- | $1.4M | -$0.72 | -- | -- |
12/31/2023 | Q4 | -- | $2.1M | -$1.16 | -- | -- |
09/30/2023 | Q3 | -- | $1.8M | -$2.90 | -- | -- |
06/30/2023 | Q2 | -- | $1.1M | -$3.50 | -- | -- |
03/31/2023 | Q1 | -- | $2M | -$2.90 | -- | -- |
12/31/2022 | Q4 | -- | $2.9M | -$9.80 | -- | -- |
09/30/2022 | Q3 | -- | $2M | -$8.00 | -- | -- |
06/30/2022 | Q2 | -- | $1.6M | -$9.00 | -- | -- |
03/31/2022 | Q1 | -- | $1.6M | -$11.00 | -- | -- |
12/31/2021 | Q4 | -- | $2.9M | -$12.00 | -- | -- |
09/30/2021 | Q3 | -- | $2M | -$10.00 | -- | -- |
08/13/2021 | Q2 | -- | $2.4M | -$10.00 | -- | -- |
05/14/2021 | Q1 | -- | $2.4M | -$10.00 | -- | -- |
12/31/2020 | Q4 | -- | $2.9M | -$15.00 | -- | -- |
09/30/2020 | Q3 | -- | $2.4M | -$10.00 | -- | -- |
06/30/2020 | Q2 | -- | $3.8M | $0.15 | -- | -- |
03/31/2020 | Q1 | -- | $1.8M | -$10.00 | -- | -- |
12/31/2019 | Q4 | -- | $3M | -$220.00 | -- | -- |
09/30/2019 | Q3 | -- | $2.4M | -$10.00 | -- | -- |
06/30/2019 | Q2 | -- | $2.6M | -$10.00 | -- | -- |
03/31/2019 | Q1 | -- | $2.9M | -$5.00 | -- | -- |
12/31/2018 | Q4 | -- | $3.2M | -$90.00 | -- | -- |
09/30/2018 | Q3 | -- | $2.3M | -$20.00 | -- | -- |
06/30/2018 | Q2 | -- | $3.2M | -$10.00 | -- | -- |
03/31/2018 | Q1 | -- | $3.6M | -$5.00 | -- | -- |
12/31/2017 | Q4 | -- | $3.8M | -$155.00 | -- | -- |
09/30/2017 | Q3 | -- | $3.2M | -$25.00 | -- | -- |
06/30/2017 | Q2 | -- | $2.9M | -$25.00 | -- | -- |
03/31/2017 | Q1 | -- | $3.3M | -$10.00 | -- | -- |
12/31/2016 | Q4 | -- | $5.3M | -$40.00 | -- | -- |
09/30/2016 | Q3 | -- | $3.1M | -$20.00 | -- | -- |
06/30/2016 | Q2 | -- | $3.5M | -$30.00 | -- | -- |
03/31/2016 | Q1 | -- | $3.6M | -$20.00 | -- | -- |
12/31/2015 | Q4 | -- | $4.5M | -$70.00 | -- | -- |
09/30/2015 | Q3 | -- | $4.5M | $35.00 | -- | -- |
China Pharma Holding reported $1.1M worth of top line sales in its most recent quarter.
China Pharma Holding announced earnings per share of -$0.24 which represents a miss of analyst forecast a -- per share.
China Pharma Holding reported -$136.1K that represents -$0.04 per share over the last quarter.
China Pharma Holding's earnings are forecast to grow from -$2.70 per share to -- per share next year representing an increase of --.
China Pharma Holding's next earnings date is August 14, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.